Combination therapy with interferon-gamma as a potential therapeutic medicine in rat's glioblastoma: A multi-mechanism evaluation.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Life Science

• Publication date

  2022-07-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.lfs.2022.120744PMID 35798069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective Effects of Combining SERMs with Estrogen on Metabolic Parameters in Postmenopausal Diabetic Cardiovascular Dysfunction: The Role of Cytokines and Angiotensin II.

  2022cited by this paper
• Early postnatal handling alters social behavior, learning, and memory of pre- and post-natal VPA-induced rat models of autism in a context-based manner.

  2022cited by this paper
• Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma

  2021cited by this paper
• The effect of early handling on anxiety-like behaviors of rats exposed to valproic acid pre-and post-natally.

  2021cited by this paper
• Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress

  2021cited by this paper
• Letter: Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.

  2021cited by this paper
• Myricetin ameliorates high glucose‐induced endothelial dysfunction in human umbilical vein endothelial cells

  2020cited by this paper
• Retraction: Downregulation of uPAR and Cathepsin B Induces Apoptosis via Regulation of Bcl-2 and Bax and Inhibition of the PI3K/Akt Pathway in Gliomas

  2020cited by this paper
• AVNP2 protects against cognitive impairments induced by C6 glioma by suppressing tumour associated inflammation in rats

  2020cited by this paper
• Neurobehavioral effects in rats with experimentally induced glioblastoma after treatment with the mTOR-inhibitor rapamycin.

  2020cited by this paper
• The effects of malvidin on oxidative stress parameters and inflammatory cytokines in LPS‐induced human THP‐1 cells

  2020cited by this paper
• Prenatal pregabalin is associated with sex‐dependent alterations in some behavioral parameters in valproic acid‐induced autism in rat offspring

  2020cited by this paper
• Evolution of TLR4 role in mediating the hepatoprotective effects of estradiol after traumatic brain injury in male rats.

  2020cited by this paper
• Fluoxetine reverses brain radiation and temozolomide-induced anxiety and spatial learning and memory defect in mice.

  2019cited by this paper
• Interleukin 10 promotes growth and invasion of glioma cells by up-regulating KPNA 2 in vitro

  2019cited by this paper
• Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia.

  2019cited by this paper
• The Delicate Equilibrium between Oxidants and Antioxidants in Brain Glioma

  2019cited by this paper
• Association of environmental exposure with hematological and oxidative stress alteration in gasoline station attendants

  2019cited by this paper
• Neuropathological and genomic characterization of glioblastoma‐induced rat model: How similar is it to humans for targeted therapy?

  2019cited by this paper
• Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo

  2019cited by this paper
• Effect of pretreatment with intracerebroventricular injection of minocycline on morphine‐induced memory impairment in passive avoidance test: Role of P‐CREB and c‐Fos expression in the dorsal hippocampus and basolateral amygdala regions

  2019cited by this paper
• Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomide

  2019cited by this paper
• Sumatriptan ameliorates renal injury induced by cisplatin in mice

  2019cited by this paper
• The Interleukin-10 Family of Cytokines and Their Role in the CNS

  2018cited by this paper
• Temozolomide for immunomodulation in the treatment of glioblastoma

  2018cited by this paper
• Cognitive impairment and morphological changes after radiation therapy in brain tumors: A review.

  2018cited by this paper
• Primary brain tumours in adults.

  2018cited by this paper
• The study of the serum level of IL‐4, TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension

  2018cited by this paper
• Depletion of adult neurogenesis using the chemotherapy drug temozolomide in mice induces behavioural and biological changes relevant to depression

  2017cited by this paper
• Glioblastoma Treatment in the Elderly

  2017cited by this paper
• Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

  2017cited by this paper
• Impairments in Quality of Life and Cognitive Functions in Long-term Survivors of Glioblastoma

  2017cited by this paper
• What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?

  2016cited by this paper
• A placental growth factor-positively charged peptide potentiates the antitumor activity of interferon-gamma in human brain glioblastoma U87 cells.

  2016cited by this paper
• Role of Redox Status in Development of Glioblastoma

  2016cited by this paper
• NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells

  2016cited by this paper
• Psychiatric symptoms in glioma patients: from diagnosis to management

  2015cited by this paper
• Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.

  2015cited by this paper
• Significance of TLR4/MyD88 expression in breast cancer.

  2015cited by this paper
• Establishment of C6 brain glioma models through stereotactic technique for laser interstitial thermotherapy research

  2015cited by this paper
• Controversial Role of Toll-like Receptor 4 in Adult Stem Cells

  2015cited by this paper
• Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study

  2013cited by this paper
• Enhanced Dendritic Cell-Mediated Antigen-Specific CD4+ T Cell Responses: IFN-Gamma Aids TLR Stimulation

  2013cited by this paper
• Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain.

  2013cited by this paper
• Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.

  2013cited by this paper
• A potential antitumor agent, (6-amino-1-methyl-5-nitrosouracilato-N3)-triphenylphosphine-gold(I): structural studies and in vivo biological effects against experimental glioma.

  2013cited by this paper
• Cytokine Patterns in Brain Tumour Progression

  2013cited by this paper
• cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a

  2012cited by this paper
• CREB signalling in neural stem/progenitor cells: Recent developments and the implications for brain tumour biology

  2012cited by this paper
• Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress

  2012cited by this paper
• Cell mediated immune responses through TLR4 prevents DMBA‐induced mammary carcinogenesis in mice

  2012cited by this paper
• The cellular origin for malignant glioma and prospects for clinical advancements

  2012cited by this paper
• CREB is a novel nuclear target of PTEN phosphatase.

  2011cited by this paper
• TLR4 signal transduction pathways neutralize the effect of Fas signals on glioblastoma cell proliferation and migration.

  2011cited by this paper
• Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.

  2010cited by this paper
• The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker

  2010cited by this paper
• Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

  2010cited by this paper
• Role of CREB in modulation of TNFalpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages.

  2010cited by this paper
• The regulation of IL-10 production by immune cells

  2010cited by this paper
• Nitric oxide induction of IRE1-alpha-dependent CREB phosphorylation in human glioma cells.

  2010cited by this paper
• Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma.

  2010cited by this paper
• Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion

  2010cited by this paper
• The ceramide‐1‐phosphate analogue PCERA‐1 modulates tumour necrosis factor‐α and interleukin‐10 production in macrophages via the cAMP–PKA–CREB pathway in a GTP‐dependent manner

  2010cited by this paper
• Noradrenaline induces clock gene Per1 mRNA expression in C6 glioma cells through beta(2)-adrenergic receptor coupled with protein kinase A - cAMP response element binding protein (PKA-CREB) and Src-tyrosine kinase - glycogen synthase kinase-3beta (Src-GSK-3beta).

  2010cited by this paper
• Towards a knowledge-based Human Protein Atlas

  2010cited by this paper
• Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition*

  2010cited by this paper
• Interferon-gamma in brain tumor immunotherapy.

  2010cited by this paper
• Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.

  2009cited by this paper
• IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB.

  2009cited by this paper
• Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model.

  2009cited by this paper
• Clinical Use of Interferon‐γ

  2009cited by this paper
• Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model

  2009cited by this paper
• Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas

  2009cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• Pretreatment with interferon-gamma protects microglia from oxidative stress via up-regulation of Mn-SOD.

  2009cited by this paper
• The use of chemotherapy in patients with gliomas: patterns of care in Victoria from 1998-2000.

  2008cited by this paper
• Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.

  2008cited by this paper
• The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling

  2008cited by this paper
• The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.

  2007cited by this paper
• Relationship between DNA damage and total antioxidant capacity in patients with transitional meningioma.

  2007cited by this paper
• Interferons at age 50: past, current and future impact on biomedicine

  2007cited by this paper
• Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme.

  2007cited by this paper
• cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation

  2007cited by this paper
• Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.

  2007cited by this paper
• Regulation of interferon-gamma during innate and adaptive immune responses.

  2007cited by this paper
• Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits

  2007cited by this paper
• THE IN VIVO ANTITUMORAL EFFECTS OF LIPOPOLYSACCHARIDE AGAINST GLIOBLASTOMA MULTIFORME ARE MEDIATED IN PART BY TOLL‐LIKE RECEPTOR 4

  2007cited by this paper
• Glutathione peroxidase, glutathione reductase and protein oxidation in patients with glioblastoma multiforme and transitional meningioma

  2007cited by this paper
• Brain tumor and role of beta-carotene, a-tocopherol, superoxide dismutase and glutathione peroxidase.

  2006cited by this paper
• Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.

  2006cited by this paper
• TNF-alpha in promotion and progression of cancer.

  2006cited by this paper
• Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.

  2006cited by this paper
• CREB: the unindicted cancer co-conspirator.

  2005cited by this paper
• The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.

  2005cited by this paper
• Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions.

  2005cited by this paper
• Differential Activation of the Transcription Factor Cyclic AMP Response Element Binding Protein (CREB) in Macrophages following Infection with Pathogenic and Nonpathogenic Mycobacteria and Role for CREB in Tumor Necrosis Factor Alpha Production

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis.

  2005cited by this paper
• Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles

  2004cited by this paper
• Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

  2004cited by this paper

• The therapeutic potential of high-intensity interval training in a breast cancer model: focus on the Hippo signaling pathway

  2025cites this paper
• Therapeutic efficacy to dose-dependent toxicity of Cabazitaxel in C6-induced glioblastoma model of rats.

  2025cites this paper
• Novel effects of vericiguat, alone and combined with high-intensity interval training, on brain function in mice with breast cancer: a histopathological and behavioral study.

  2025cites this paper
• New experimental therapies for glioblastoma: a review of preclinical research

  2025cites this paper
• M2 macrophage-targeting peptide-modified liposomes enhance the uptake and antitumor efficacy of liposomal IFN-γ in mice with C26 colon carcinoma.

  2025cites this paper
• Preventive effect of MitoQ supplementation and endurance training on glioblastoma and its consequences: TLR4/CREB/ NF-κβ /IL-1β pathway and behaviors.

  2024cites this paper
• Changes in the hippocampal level of tau but not beta-amyloid may mediate anxiety-like behavior improvement ensuing from exercise in diabetic female rats

  2024cites this paper
• Selenoprotein P expression in glioblastoma as a regulator of ferroptosis sensitivity: preservation of GPX4 via the cycling-selenium storage

  2024cites this paper
• Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment

  2024cites this paper
• Sex‐dependent alterations of inflammatory factors, oxidative stress, and histopathology of the brain‐gut axis in a VPA‐induced autistic‐like model of rats

  2024cites this paper
• Therapeutic Implications of Targeting YY1 in Glioblastoma

  2024cites this paper
• Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy.

  2023cites this paper
• Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals

  2023cites this paper
• The effect of low- and moderate-intensity interval training on cognitive behaviors of male and female rats with VPA-induced autism

  2023cites this paper
• Autophagy in combination therapy of temozolomide and IFN-γ in C6-induced glioblastoma: role of non-coding RNAs.

  2023cites this paper